-
Forward Look
Cancer Treatment Can Reactivate Hepatitis BResearchers make the case for screening cancer patients for hepatitis B before treatment.
by Yasmine Iqbal
-
Forward Look
First Biosimilar Drug Approved in U.S.New drugs will offer same effectiveness, but at a lower cost.
by Stephen Ornes
-
The DCIS Dilemma
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Healthy Habits
Reaping the BenefitsFollowing a vegetarian diet could reduce your risk of colorectal cancer.
by Leigh Labrie
-
Q&A
The Language of CancerResearcher David J. Hauser discusses how war metaphors may make people less likely to engage in preventive behaviors.
by Sharlene George
-
Preserving the Future
Young adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
-
From the Editor-in-Chief
Inheritance, ‘Bad Luck’ and the EnvironmentWhy do some people develop cancer while others do not?
by William G. Nelson, MD, PhD
-
From the Editor-in-Chief
The Promise of Precision MedicineThe impact of gene sequencing on the discovery and development of cancer treatments could be profound.
by William G. Nelson, MD, PhD
-
Forward Look
Genetic Testing Can Help Women With Triple-Negative Breast CancerStudy confirms inherited genetic mutations are common, regardless of family history.
by Kendall K. Morgan
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles